Sofinnova Investments related stories
All articles and analysis
Intellikine Signs $488 Million Deal with Infinity PharmaIntellikine Inc. has sold global development and commercialization rights to its portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase Infinity Pharmaceuticals Inc. (Nasdaq: INFI). The deal could be worth upwards of $488.5 million, including a $13.5 million up-front payment. Intellikine has raised over $63 million in VC funding from Abingworth, CMEA Capital, Novartis Bioventures, U.S. Venture Partners, Biogen Idec, FinTech Global Capital and Sofinnova Ventures.
- peHUB Wire: Friday, July 9, 2010
Random Ramblings
- peHUB Wire: Friday, July 9, 2010
Random Ramblings
- Week in deals, June 28, 2010
Summary of tech companies and other startups in North America that raised venture financing in the past week
- Startup CEOs earning more
Higher compensation said to compensate for longer time to exit, according to NVCA-backed survey
- peHUB Wire: Thursday, June 17, 2010
Random Ramblings
- peHUB Wire: Thursday, June 17, 2010
Random Ramblings
- KXEN Raises $8 Million
KXEN, a San Francisco-based provider of data mining automation solutions, has raised $8 million in Series D funding. Next Stage led the round, and was joined by existing backers XAnge Capital, Sofinnova Ventures, Saints Capital and Motorola Ventures.
- VC-Backed IPO Pipeline Remains Clogged
It's been a slow month for VC-backed IPOs, with just three new companies filing and three going public. In fact, only two even bothered to ammend their proposed pricing terms. The newbies were ZipCar, TripeWire and NuPathe, while the recently-listed were Accretive Health, JinkoSolar and TeleNav. That means the VC-backed IPO pipeline remains static with 43 total registrants, but also a bit lighter since the filers are seeking less money than were those that priced. Overall, VC-backed companies in registration to go public are aiming to raise nearly $4.5 billion. The full pipeline is after the jump...
- Crocus Technology Raises €8 Million
Crocus Technology, a France-based developer of magnetic random access memory (MRAM), has raised €8 million in third-round funding. Return backers include AGF Private Equity, CDC Innovation, CEA Investissement, Nanodimension, Sofinnova Ventures and Ventech.